Blue Diamond Ventures Inc (BLDV)

[JPS02]

Question 8 is key: In mid-May, Jonathan Alper conducted a second round of meetings with a technology accelerator and multiple medical device manufacturers and IP holders, this round was focused on logistics and export/import standards.

I believe the key value prospects in this CC response are based on the following four important items presented in the response:

1. Technology accelerator

2. Multiple medical device manufacturers

3. IP holders

4. Logistics and export/import standards

Any single or combination of items 1 to 3 plus item 4 can bring significant value to a company in general.

We know that something is going on with BLDV, Eltron Research, Israel and MJ that is timely based on the industry dynamics, Isreal's leadership in the industry and the prior updates we have received from BLDV:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132391537

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132085237

These updates and the CC response are supported by the CEO's statement at 9:45 in the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where the CEO describes the amount of efforts they have expended to develop the Israel connection to build a couple of partnerships that will drive significant revenue by the end of the year.

Time will tell how significant the Israeli partnerships will be to BLDV.

Go BLDV!